Hello and Welcome to Patientsville.com, Your Source for all CERTICAN information. We are dedicated to provide You with CERTICAN safety information. Learn about CERTICAN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
CERTICAN Safety Reports
Total CERTICAN reports: 97.CERTICAN FDA safety alerts: No.
Reported deaths: 5 Reported hospitalizations: 85.
Take CERTICAN Side Effects Survey or Share Your CERTICAN Story. Read More Here.
Showing 1-75 of 97 Next >
Physician from BRAZIL reported CERTICAN problem on July 19, 2007. Female patient, 30 years of age, weighting 116.8 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, haemolytic anaemia, kidney fibrosis, oedema, post procedural haemorrhage, red blood cell abnormality, renal impairment, renal tubular necrosis, renal vessel disorder. CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with NEORAL, PREDNISONE. Patient was hospitalized. Patient recovered.CERTICAN problem was reported by a Physician from SPAIN on July 24, 2007. Female patient, 58 years of age, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, atrial fibrillation, complications of transplant surgery, deep vein thrombosis, diarrhoea, gastrointestinal haemorrhage, herpes simplex, hyperuricaemia, nephropathy toxic. CERTICAN dosage: 0.5 MG, BID. During the same period patient was treated with SEGURIL, NEORAL, SIMULECT. Patient was hospitalized. Patient died on 06/29/2007.
Physician from UNITED STATES reported CERTICAN problem on July 24, 2007. Female patient, 42 years of age, weighting 153.7 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: cellulitis, dermatitis contact, disease progression, erythema, oedema peripheral, renal impairment, systemic lupus erythematosus. CERTICAN dosage: 720 MG, BID. During the same period patient was treated with NEORAL, NORVASC, LIPITOR, NEURONTIN, MAGNESIUM OXIDE, LOPRESSOR, VITAMIN CAP, PROTONIX. Patient was hospitalized. Patient recovered.
CERTICAN problem was reported by a Physician from GERMANY on July 23, 2007. Male patient was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: alveolitis, carbon monoxide diffusing capacity decreased, cough, dyspnoea, interstitial lung disease, lung infection, respiratory failure. CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with MYFORTIC, PREDNISONE. Patient was hospitalized. Patient recovered.
Physician from AUSTRIA reported CERTICAN problem on July 23, 2007. Female patient, 61 years of age, weighting 158.7 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol abnormal, blood creatinine abnormal, blood creatinine increased, blood triglycerides abnormal, diabetes mellitus inadequate control, glomerulonephritis membranous, haemoglobin abnormal, nephropathy toxic, oedema peripheral. CERTICAN dosage: unknown. During the same period patient was treated with MYFORTIC. Patient recovered.
CERTICAN problem was reported by a Physician from BRAZIL on July 25, 2007. Male patient, 20 years of age, weighting 113.5 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, dyspnoea, fluid overload, lymphocele, nephropathy toxic, oedema, renal impairment, surgery. CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with NEORAL. Patient recovered.
Physician from SINGAPORE reported CERTICAN problem on July 26, 2007. Female patient, 36 years of age, weighting 114.0 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: brain mass, epstein-barr virus antibody positive, headache, intracranial pressure increased. CERTICAN dosage: 360 MG, BID. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.
CERTICAN problem was reported by a Physician from GERMANY on July 26, 2007. Male patient, 48 years of age, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: hip arthroplasty, osteonecrosis. CERTICAN dosage: 4.5 MG, UNK. During the same period patient was treated with PREDNISOLONE, MYFORTIC. Patient was hospitalized. Patient recovered.
Physician from SINGAPORE reported CERTICAN problem on July 26, 2007. Female patient, 36 years of age, weighting 114.0 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: brain mass, epstein-barr virus antibody positive, headache, intracranial pressure increased. CERTICAN dosage: 360 MG, BID. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.
CERTICAN problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Male patient, 53 years of age, weighting 165.3 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: anaemia, chest pain, chills, dyspnoea, haematocrit decreased, hyperglycaemia, hypertension, hypoxia, leukocytosis. CERTICAN dosage: 720 MG, BID. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported CERTICAN problem on Aug 08, 2007. Male patient, 43 years of age, weighting 173.7 lb, was diagnosed with prophylaxis against transplant rejection, renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: bk virus infection, blood creatinine increased, nephropathy toxic, renal vessel disorder. CERTICAN dosage: 720 MG, BID. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.
CERTICAN problem was reported by a Physician from SINGAPORE on Aug 10, 2007. Female patient, 36 years of age, weighting 114.0 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus antibody positive, headache, intracranial pressure increased, primitive neuroectodermal tumour. CERTICAN dosage: 360 MG, BID. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported CERTICAN problem on Aug 07, 2007. Male patient, 33 years of age, weighting 275.6 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: arthralgia, arthritis bacterial, cholelithiasis, pyrexia, salmonellosis, synovial disorder, therapeutic aspiration. CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with PREDNISOLONE, NEORAL, EVEROLIMUS. Patient was hospitalized. Patient recovered.
CERTICAN problem was reported by a Physician from BRAZIL on Aug 16, 2007. Female patient, 30 years of age, weighting 116.8 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: complications of transplanted kidney, haemoglobin decreased, haemolytic anaemia, kidney fibrosis, kidney transplant rejection, oedema, post procedural haemorrhage, red blood cell abnormality, renal impairment. CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with NEORAL, PREDNISONE. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported CERTICAN problem on Aug 16, 2007. Male patient, 48 years of age, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: hip arthroplasty, osteonecrosis. CERTICAN dosage: 4.5 MG, UNK. During the same period patient was treated with PREDNISOLONE, MYFORTIC. Patient was hospitalized. Patient recovered.
CERTICAN problem was reported by a Physician from AUSTRIA on Aug 13, 2007. Female patient, 61 years of age, weighting 158.7 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol abnormal, blood creatinine abnormal, blood creatinine increased, blood triglycerides abnormal, chronic allograft nephropathy, diabetes mellitus inadequate control, haemoglobin abnormal, nephropathy toxic, oedema peripheral. CERTICAN dosage: unknown. During the same period patient was treated with MYFORTIC. Patient was hospitalized. Patient recovered.
Physician from BRAZIL reported CERTICAN problem on Aug 24, 2007. Male patient, 20 years of age, weighting 113.5 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, dyspnoea, fluid overload, lymphocele, nephropathy toxic, oedema, renal impairment, surgery. CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.
CERTICAN problem was reported by a Physician from TURKEY on Aug 24, 2007. Female patient, 32 years of age, weighting 127.0 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, complications of transplanted kidney, dysuria, escherichia urinary tract infection, graft infection, pyrexia, tubulointerstitial nephritis. CERTICAN dosage: 0.5 MG, BID. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.
Physician from BRAZIL reported CERTICAN problem on Aug 24, 2007. Female patient, 30 years of age, weighting 116.8 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: complications of transplanted kidney, haemoglobin decreased, haemolytic anaemia, kidney fibrosis, kidney transplant rejection, oedema, post procedural haemorrhage, red blood cell abnormality, renal impairment. CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with NEORAL, PREDNISONE. Patient was hospitalized. Patient recovered.
CERTICAN problem was reported by a Physician from UNITED STATES on Sept 05, 2007. Male patient, 51 years of age, weighting 162.0 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: atelectasis, cough, febrile neutropenia, leukopenia. CERTICAN dosage: 720 MG, BID. During the same period patient was treated with RAPAMUNE, PREDNISOLONE, CALCITRIOL, ASPIRIN, TOPROL, NEORAL, NEUPOGEN. Patient was hospitalized. Patient recovered.
Physician from SPAIN reported CERTICAN problem on Sept 20, 2007. Male patient, 46 years of age, weighting 147.7 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: disease progression, enterococcal infection, pyrexia, renal impairment, urosepsis. CERTICAN dosage: 2.5MG DAILY. During the same period patient was treated with URBASON, NEORAL, STEROIDS NOS. Patient was hospitalized. Patient recovered.
CERTICAN problem was reported by a Physician from SPAIN on Sept 20, 2007. Male patient, 46 years of age, weighting 147.7 lb, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: disease progression, enterococcal infection, pyrexia, renal impairment, urosepsis. CERTICAN dosage: 2.5MG DAILY. During the same period patient was treated with URBASON, NEORAL, STEROIDS NOS. Patient was hospitalized. Patient recovered.
Showing 1-75 of 97 Next >